“…Optimal treatment demands tumour control and preservation of laryngeal function. Radiotherapy offers the possibility of preservation of voice quality and local control rates between 80% to 95% and 65% to 85% for T1 and T2 tumours respectively (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18). Factors related to tumour (6, 7, 10, 1 I, 13, 15, 19-21, 23), patient (15,21,23) and treatment (12, 14, 16-18, 22, 24-27), explaining the heterogeneity in treatment outcome, have been searched for, especially among T2 tumours.…”